{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:22:50Z","timestamp":1793035370657,"version":"4.5.0"},"reference-count":188,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.vph.2025.107491","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T17:34:31Z","timestamp":1742319271000},"page":"107491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Clinical translation of mesenchymal stem cells in ischemic heart failure: Challenges and future perspectives"],"prefix":"10.1016","volume":"159","author":[{"given":"Anqi","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Alibrandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elika","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niketa","family":"Sareen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingdong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Lionetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2025.107491_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5334\/gh.1098","article-title":"Mesenchymal stem cell (MSCs) therapy for ischemic heart disease: a promising frontier","volume":"17","author":"Poomani","year":"2022","journal-title":"Glob. Heart"},{"key":"10.1016\/j.vph.2025.107491_bb0010","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/oxfordjournals.eurheartj.a015434","article-title":"The burden of cardiovascular diseases mortality in Europe. Task force of the European Society of Cardiology on cardiovascular mortality and morbidity statistics in Europe","volume":"18","author":"Sans","year":"1997","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2025.107491_bb0015","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/CIRCULATIONAHA.118.038001","article-title":"Battling cardiovascular diseases in a perfect storm","volume":"139","author":"Sliwa","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107491_bb0020","doi-asserted-by":"crossref","unstructured":"A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, M.J. Blaha, S. Dai, E.S. Ford, C.S. Fox, S. Franco, H.J. Fullerton, C. Gillespie, S.M. Hailpern, J.A. Heit, V.J. Howard, M.D. Huffman, S.E. Judd, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, R.H. Mackey, D.J. Magid, G.M. Marcus, A. Marelli, D.B. Matchar, D.K. McGuire, E.R. Mohler, C.S. Moy, M.E. Mussolino, R.W. Neumar, G. Nichol, D.K. Pandey, N.P. Paynter, M.J. Reeves, P.D. Sorlie, J. Stein, A. Towfighi, T.N. Turan, S.S. Virani, N.D. Wong, D. Woo, M.B. Turner, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Heart disease and stroke statistics--2014 update: a report from the American Heart Association, Circulation 129 (2014) e28\u2013e292. doi: https:\/\/doi.org\/10.1161\/01.cir.0000441139.02102.80.","DOI":"10.1161\/01.cir.0000441139.02102.80"},{"key":"10.1016\/j.vph.2025.107491_bb0025","first-page":"608","article-title":"Mesenchymal stem cell therapy for patients with ischemic heart failure- past, present, and future","volume":"16","author":"Liang","year":"2021","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.vph.2025.107491_bb0030","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1582-4934.2011.01471.x","article-title":"Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators","volume":"16","author":"Wen","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.vph.2025.107491_bb0035","doi-asserted-by":"crossref","first-page":"H213","DOI":"10.1152\/ajpheart.00065.2019","article-title":"Inflammation in myocardial injury: mesenchymal stem cells as potential immunomodulators","volume":"317","author":"Yan","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2025.107491_bb0040","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1139\/cjpp-2014-0468","article-title":"Stem cell therapy for cardiac regeneration: hits and misses","volume":"93","author":"Padda","year":"2015","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.vph.2025.107491_bb0045","first-page":"1265","article-title":"Canadian cardiovascular outcomes research team, regional variation in self-reported heart disease prevalence in Canada","volume":"21","author":"Chow","year":"2005","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.vph.2025.107491_bb0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cpcardiol.2009.10.002","article-title":"Growing epidemic of coronary heart disease in low- and middle-income countries","volume":"35","author":"Gaziano","year":"2010","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.vph.2025.107491_bb0055","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1186\/s13287-021-02667-1","article-title":"Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials","volume":"12","author":"Attar","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.vph.2025.107491_bb0060","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41419-020-2542-9","article-title":"The therapeutic potential of mesenchymal stem cells for cardiovascular diseases","volume":"11","author":"Guo","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.vph.2025.107491_bb0065","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1139\/cjpp-2020-0413","article-title":"Role of prostaglandin E2 in allogeneic mesenchymal stem cell therapy for cardiac repair","volume":"99","author":"Sareen","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.vph.2025.107491_bb0070","first-page":"1","article-title":"Stem cell-based therapy for human diseases","volume":"7","author":"Hoang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.vph.2025.107491_bb0075","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.111.243147","article-title":"Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease","volume":"109","author":"Williams","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0085","doi-asserted-by":"crossref","first-page":"H1290","DOI":"10.1152\/ajpheart.00317.2020","article-title":"Metformin impairs homing ability and efficacy of mesenchymal stem cells for cardiac repair in streptozotocin-induced diabetic cardiomyopathy in rats","volume":"320","author":"Ammar","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2025.107491_bb0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1139\/cjpp-2023-0202","article-title":"Stem cell therapy for cardiac regeneration: past, present, and future","volume":"102","author":"Gill","year":"2024","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.vph.2025.107491_bb0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5581\/1516-8484.20130017","article-title":"Immunological characteristics of mesenchymal stem cells","volume":"35","author":"de Machado","year":"2013","journal-title":"Rev. Bras. Hematol. E Hemoter."},{"key":"10.1016\/j.vph.2025.107491_bb0100","doi-asserted-by":"crossref","first-page":"8898221","DOI":"10.1155\/2020\/8898221","article-title":"Differentiation potential of early- and late-passage adipose-derived mesenchymal stem cells cultured under hypoxia and Normoxia","volume":"2020","author":"Zhao","year":"2020","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.vph.2025.107491_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2023.12.009","article-title":"Stem cell-based therapy in cardiac repair after myocardial infarction: promise, challenges, and future directions","volume":"188","author":"Yan","year":"2024","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.vph.2025.107491_bb0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/157488808786734015","article-title":"Stem cells and cardiac disease: where are we going?","volume":"3","author":"Pelacho","year":"2008","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.vph.2025.107491_bb0115","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s13770-021-00334-3","article-title":"Mesenchymal stem cell transplantation for ischemic diseases: mechanisms and challenges","volume":"18","author":"Van Nguyen","year":"2021","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/j.vph.2025.107491_bb0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fcvm.2018.00101","article-title":"Cardiomyocyte-endothelial cell interactions in cardiac remodeling and regeneration","volume":"5","author":"Talman","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.vph.2025.107491_bb0125","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1113\/JP276758","article-title":"Endothelial cell-cardiomyocyte crosstalk in heart development and disease","volume":"598","author":"Colliva","year":"2020","journal-title":"J. Physiol."},{"key":"10.1016\/j.vph.2025.107491_bb0130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2184.1970.tb00347.x","article-title":"The development of fibroblast colonies in monolayer cultures of Guinea-pig bone marrow and spleen cells","volume":"3","author":"Friedenstein","year":"1970","journal-title":"Cell Prolif."},{"key":"10.1016\/j.vph.2025.107491_bb0135","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","article-title":"Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues","volume":"6","author":"Friedenstein","year":"1968","journal-title":"Transplantation"},{"key":"10.1016\/j.vph.2025.107491_bb0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/8756-3282(92)90364-3","article-title":"Characterization of cells with osteogenic potential from human marrow","volume":"13","author":"Haynesworth","year":"1992","journal-title":"Bone"},{"key":"10.1016\/j.vph.2025.107491_bb0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13287-015-0142-x","article-title":"Comparison of adipose tissue- and bone marrow- derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats","volume":"6","author":"Ammar","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.vph.2025.107491_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166412","article-title":"The role of autophagy in the metabolism and differentiation of stem cells","volume":"1868","author":"Adelipour","year":"2022","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.vph.2025.107491_bb0155","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.116.303614","article-title":"Use of mesenchymal stem cells for therapy of cardiac disease","volume":"116","author":"Karantalis","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0160","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1089\/ars.2009.2455","article-title":"Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration","volume":"11","author":"Paul","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.vph.2025.107491_bb0165","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.113.300219","article-title":"Cell therapy for heart failure","volume":"113","author":"Sanganalmath","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0170","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.vph.2025.107491_bb0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cyto.a.23242","article-title":"Isolation, cultivation, and characterization of human mesenchymal stem cells","volume":"93","author":"Mushahary","year":"2018","journal-title":"Cytomet. A"},{"key":"10.1016\/j.vph.2025.107491_bb0180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1478-811X-9-12","article-title":"Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC","volume":"9","author":"Hass","year":"2011","journal-title":"Cell Commun. Signal. CCS"},{"key":"10.1016\/j.vph.2025.107491_bb0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13287-020-01661-3","article-title":"A comparison of the use of adipose-derived and bone marrow-derived stem cells for peripheral nerve regeneration in vitro and in vivo","volume":"11","author":"Zhou","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.vph.2025.107491_bb0190","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm3049","article-title":"The elusive nature and function of mesenchymal stem cells","volume":"12","author":"Nombela-Arrieta","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.vph.2025.107491_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba6884","article-title":"Shattering barriers toward clinically meaningful MSC therapies","volume":"6","author":"Levy","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.vph.2025.107491_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15283\/ijsc17061","article-title":"Mesenchymal stem cell therapy for ischemic heart disease: systematic review and meta-analysis","volume":"11","author":"Jeong","year":"2018","journal-title":"Int. J. Stem Cells"},{"key":"10.1016\/j.vph.2025.107491_bb0205","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/ejhf.2772","article-title":"Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction \u2013 the SCIENCE trial","volume":"25","author":"Qayyum","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.vph.2025.107491_bb0210","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2022.11.061","article-title":"Randomized trial of targeted Transendocardial mesenchymal precursor cell therapy in patients with heart failure","volume":"81","author":"Perin","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2025.107491_bb0570","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/eurheartj\/ehp265","article-title":"Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy","volume":"30","author":"Schuleri","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2025.107491_bb0575","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.athoracsur.2008.11.057","article-title":"Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage","volume":"87","author":"Hamamoto","year":"2009","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.vph.2025.107491_bb0580","doi-asserted-by":"crossref","DOI":"10.1038\/srep31528","article-title":"Bone marrow mesenchymal stem cells (BM-MSCs) improve heart function in swine myocardial infarction model through paracrine effects","volume":"6","author":"Cai","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vph.2025.107491_bb0585","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13287-018-0888-z","article-title":"Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction","volume":"9","author":"Lim","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.vph.2025.107491_bb0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057759","article-title":"Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study","volume":"8","author":"Emmert","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vph.2025.107491_bb0595","doi-asserted-by":"crossref","first-page":"685","DOI":"10.5966\/sctm.2012-0027","article-title":"Mesenchymal stem cell transplantation improves regional cardiac remodeling following ovine infarction","volume":"1","author":"Zhao","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.vph.2025.107491_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1186574","article-title":"Human-umbilical cord matrix mesenchymal cells improved left ventricular contractility independently of infarct size in swine myocardial infarction with reperfusion","volume":"10","author":"Raposo","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.vph.2025.107491_bb0605","first-page":"218","article-title":"Human mesenchymal stromal cells improve cardiac perfusion in an ovine immunocompetent animal model","volume":"29","author":"Dayan","year":"2016","journal-title":"J. Investig. Surg. Off. J. Acad. Surg. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0610","first-page":"10","article-title":"Translation of methodology used in human myocardial imaging to a sheep model of acute myocardial infarction","volume":"1","author":"Bailey","year":"2013","journal-title":"Asia Ocean J. Nucl. Med. Biol."},{"key":"10.1016\/j.vph.2025.107491_bb0615","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/01.CIR.0000151812.86142.45","article-title":"Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model","volume":"111","author":"Silva","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107491_bb0145","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/461718","article-title":"Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications","volume":"2012","author":"Orbay","year":"2012","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.vph.2025.107491_bb0215","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCRESAHA.115.305227","article-title":"Empowering adult stem cells for myocardial regeneration V2.0: success in small steps","volume":"118","author":"Broughton","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0220","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013784","article-title":"Tailorable hydrogel improves retention and cardioprotection of intramyocardial transplanted mesenchymal stem cells for the treatment of acute myocardial infarction in mice","volume":"9","author":"Chen","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.vph.2025.107491_bb0225","article-title":"Mesenchymal stromal cells overexpressing farnesoid X receptor exert cardioprotective effects against acute ischemic heart injury by binding endogenous bile acids","volume":"9","author":"Xia","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.vph.2025.107491_bb0230","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/CIRCRESAHA.119.315806","article-title":"N-cadherin overexpression mobilizes the protective effects of mesenchymal stromal cells against ischemic heart injury through a \u03b2-catenin\u2013dependent manner","volume":"126","author":"Yan","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103697","article-title":"Irisin promotes cardiac homing of intravenously delivered MSCs and protects against ischemic heart injury","volume":"9","author":"Yan","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.vph.2025.107491_bb0240","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/cvr\/cvr018","article-title":"Placental stem cells pre-treated with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig hearts: a multimodal study","volume":"90","author":"Simioniuc","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0245","doi-asserted-by":"crossref","first-page":"14243","DOI":"10.1074\/jbc.M609350200","article-title":"Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts","volume":"282","author":"Ventura","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2025.107491_bb0250","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/CIRCRESAHA.117.311302","article-title":"Meta-analysis of cell therapy studies in heart failure and acute myocardial infarction","volume":"123","author":"Gy\u00f6ngy\u00f6si","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0265","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.exphem.2008.03.006","article-title":"Immunosuppression by mesenchymal stromal cells: from culture to clinic","volume":"36","author":"Jones","year":"2008","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.vph.2025.107491_bb0255","first-page":"3306","article-title":"The immune system in Parkinson\u2019s disease: what we know so far, brain","volume":"147","author":"Roodveldt","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.vph.2025.107491_bb0260","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","article-title":"Cardioimmunology: the immune system in cardiac homeostasis and disease","volume":"18","author":"Swirski","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vph.2025.107491_bb0270","first-page":"15236","article-title":"Hypoxia-induced downregulation of cyclooxygenase 2 leads to the loss of immunoprivilege of allogeneic mesenchymal stem cells, FASEB","volume":"34","author":"Sareen","year":"2020","journal-title":"J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.vph.2025.107491_bb0275","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41423-023-00998-y","article-title":"Immunomodulatory properties of mesenchymal stem cells\/dental stem cells and their therapeutic applications","volume":"20","author":"Li","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.vph.2025.107491_bb0280","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","article-title":"Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential","volume":"41","author":"Song","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.vph.2025.107491_bb0285","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","article-title":"Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases","volume":"14","author":"Shi","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.vph.2025.107491_bb0290","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/jcm8071025","article-title":"The immunomodulatory functions of mesenchymal stromal\/stem cells mediated via paracrine activity","volume":"8","author":"Zhou","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.vph.2025.107491_bb0295","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s13287-020-01855-9","article-title":"Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress","volume":"11","author":"Wu","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.vph.2025.107491_bb0300","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/181020","article-title":"Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors","volume":"2013","author":"van den Akker","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.vph.2025.107491_bb0305","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7828","article-title":"Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation","volume":"9","author":"Galleu","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.vph.2025.107491_bb0310","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12712","article-title":"Immune modulation by mesenchymal stem cells","volume":"53","author":"Jiang","year":"2020","journal-title":"Cell Prolif."},{"key":"10.1016\/j.vph.2025.107491_bb0315","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s13287-020-01937-8","article-title":"Mesenchymal stem cell-derived extracellular vesicles alter disease outcomes via endorsement of macrophage polarization","volume":"11","author":"Wang","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.vph.2025.107491_bb0320","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41420-022-01235-7","article-title":"Inflammation in myocardial infarction: roles of mesenchymal stem cells and their secretome","volume":"8","author":"Shao","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.vph.2025.107491_bb0325","first-page":"1","article-title":"Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.vph.2025.107491_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166806","article-title":"Stem cells derived exosomes and biomaterials to modulate autophagy and mend broken hearts","volume":"1869","author":"Sareen","year":"2023","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.vph.2025.107491_bb0335","article-title":"All roads Lead to Rome (the heart): cell retention and outcomes from various delivery routes of cell therapy products to the heart","volume":"10","author":"Li","year":"2021","journal-title":"J. Am. Heart Assoc. Cardiovasc Cerebrovasc. Dis."},{"key":"10.1016\/j.vph.2025.107491_bb0340","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.stem.2015.12.004","article-title":"To serve and protect: hydrogels to improve stem cell-based therapies","volume":"18","author":"Burdick","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.vph.2025.107491_bb0345","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biomaterials.2015.12.032","article-title":"Injectable hydrogel promotes early survival of induced pluripotent stem cell-derived oligodendrocytes and attenuates longterm teratoma formation in a spinal cord injury model","volume":"83","author":"F\u00fchrmann","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.vph.2025.107491_bb0350","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41586-018-0089-z","article-title":"Bioengineering strategies to accelerate stem cell therapeutics","volume":"557","author":"Madl","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.vph.2025.107491_bb0355","article-title":"Treatment of myocardial infarction with gene-modified mesenchymal stem cells in a small molecular hydrogel","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vph.2025.107491_bb0360","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/hc0102.101442","article-title":"Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart","volume":"105","author":"Toma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107491_bb0365","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1089\/hum.2011.009","article-title":"Mesenchymal stem cell survival in the infarcted heart is enhanced by lentivirus vector-mediated heat shock protein 27 expression","volume":"24","author":"McGinley","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.vph.2025.107491_bb0370","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.CIR.0000163546.27639.AA","article-title":"Monitoring of bone marrow cell homing into the infarcted human myocardium","volume":"111","author":"Hofmann","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107491_bb0375","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ultras.2011.08.013","article-title":"Enhanced homing of mesenchymal stem cells to the ischemic myocardium by ultrasound-targeted microbubble destruction","volume":"52","author":"Zhong","year":"2012","journal-title":"Ultrasonics"},{"key":"10.1016\/j.vph.2025.107491_bb0380","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/stem.3079","article-title":"Understanding and leveraging cell metabolism to enhance mesenchymal stem cell transplantation survival in tissue engineering and regenerative medicine applications","volume":"38","author":"Salazar-Noratto","year":"2020","journal-title":"Stem Cells"},{"key":"10.1016\/j.vph.2025.107491_bb0385","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1161\/CIRCULATIONAHA.104.527226","article-title":"Endothelium-derived nitric oxide regulates postischemic myocardial oxygenation and oxygen consumption by modulation of mitochondrial electron transport","volume":"111","author":"Zhao","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107491_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-0579-9","article-title":"Leptin increases mitochondrial OPA1 via GSK3-mediated OMA1 ubiquitination to enhance therapeutic effects of mesenchymal stem cell transplantation","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.vph.2025.107491_bb0395","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s13287-022-03016-6","article-title":"Andrographolide protects bone marrow mesenchymal stem cells against glucose and serum deprivation under hypoxia via the NRF2 signaling pathway","volume":"13","author":"Sun","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.vph.2025.107491_bb0400","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2106\/00004623-200407000-00029","article-title":"Engineering principles of clinical cell-based tissue engineering","volume":"86","author":"Muschler","year":"2004","journal-title":"JBJS"},{"key":"10.1016\/j.vph.2025.107491_bb0405","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13287-016-0436-7","article-title":"Mesenchymal stem cells\/multipotent stromal cells (MSCs) are glycolytic and thus glucose is a limiting factor of in vitro models of MSC starvation","volume":"7","author":"Nuschke","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.vph.2025.107491_bb0410","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/stem.1299","article-title":"Proangiogenic and prosurvival functions of glucose in human mesenchymal stem cells upon transplantation","volume":"31","author":"Deschepper","year":"2013","journal-title":"Stem Cells Dayt. Ohio"},{"key":"10.1016\/j.vph.2025.107491_bb0415","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1468833","article-title":"Rebuilding the myocardial microenvironment to enhance mesenchymal stem cells-mediated regeneration in ischemic heart disease","volume":"12","author":"Chu","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.vph.2025.107491_bb0420","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s12015-022-10468-z","article-title":"Combined transplantation of human MSCs and ECFCs improves cardiac function and decrease cardiomyocyte apoptosis after acute myocardial infarction","volume":"19","author":"Tripathi","year":"2023","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.vph.2025.107491_bb0425","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/cvr\/cvv197","article-title":"Transplantation of adipose tissue mesenchymal cells conjugated with VEGF-releasing microcarriers promotes repair in murine myocardial infarction","volume":"108","author":"Madonna","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0430","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biomaterials.2015.04.046","article-title":"Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction","volume":"60","author":"Yao","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.vph.2025.107491_bb0435","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.3390\/ijms20225680","article-title":"The importance of HLA assessment in \u201coff-the-shelf\u201d allogeneic mesenchymal stem cells based-therapies","volume":"20","author":"Kot","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vph.2025.107491_bb0440","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/agm2.12079","article-title":"Allogeneic mesenchymal stem cell therapy: a regenerative medicine approach to geroscience","volume":"2","author":"Oliva","year":"2019","journal-title":"Aging Med."},{"key":"10.1016\/j.vph.2025.107491_bb0455","first-page":"12860","article-title":"Hypoxia-induced increase in Sug1 leads to poor post-transplantation survival of allogeneic mesenchymal stem cells","volume":"34","author":"Abu-El-Rub","year":"2020","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc Exp. Biol."},{"key":"10.1016\/j.vph.2025.107491_bb0465","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41419-020-2634-6","article-title":"Hypoxia-induced shift in the phenotype of proteasome from 26S toward immunoproteasome triggers loss of immunoprivilege of mesenchymal stem cells","volume":"11","author":"Abu-El-Rub","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.vph.2025.107491_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.690623","article-title":"From mesenchymal stromal\/stem cells to insulin-producing cells: immunological considerations","volume":"12","author":"Refaie","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vph.2025.107491_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-1359-x","article-title":"Hypoxia-induced 26S proteasome dysfunction increases immunogenicity of mesenchymal stem cells","volume":"10","author":"Abu-El-Rub","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.vph.2025.107491_bb0470","article-title":"The major histocompatibility complex in transplantation","volume":"2012","author":"Ayala Garc\u00eda","year":"2012","journal-title":"J. Transp. Secur."},{"key":"10.1016\/j.vph.2025.107491_bb0475","first-page":"3069","article-title":"Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart","volume":"30","author":"Huang","year":"2016","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.vph.2025.107491_bb0480","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.tcm.2011.12.002","article-title":"Challenges in allogeneic mesenchymal stem cell\u2013mediated cardiac repair","volume":"20","author":"Dhingra","year":"2010","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.vph.2025.107491_bb0485","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s13287-017-0742-8","article-title":"Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells","volume":"8","author":"Berglund","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.vph.2025.107491_bb0460","series-title":"Interleukin-6 Downregulation with Mesenchymal Stem Cell Differentiation Results in Loss of Immunoprivilege","author":"Li","year":"2025"},{"key":"10.1016\/j.vph.2025.107491_bb0505","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13287-018-0867-4","article-title":"Early passaging of mesenchymal stem cells does not instigate significant modifications in their immunological behavior","volume":"9","author":"Sareen","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.vph.2025.107491_bb0510","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","article-title":"Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting","volume":"108","author":"Nauta","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.vph.2025.107491_bb0515","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/01.tp.0000258649.23081.a3","article-title":"Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo","volume":"83","author":"Poncelet","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.vph.2025.107491_bb0520","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1182\/blood-2005-03-1004","article-title":"Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice","volume":"106","author":"Eliopoulos","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.vph.2025.107491_bb0525","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bbmt.2006.12.447","article-title":"Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response","volume":"13","author":"Badillo","year":"2007","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant."},{"key":"10.1016\/j.vph.2025.107491_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087238","article-title":"Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo","volume":"9","author":"Isakova","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vph.2025.107491_bb0535","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13287-015-0053-x","article-title":"Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo","volume":"6","author":"Pezzanite","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.vph.2025.107491_bb0490","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1161\/CIRCULATIONAHA.112.000324","article-title":"Preserving prostaglandin E2 level prevents rejection of implanted allogeneic mesenchymal stem cells and restores postinfarction ventricular function","volume":"128","author":"Dhingra","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107491_bb0540","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4252\/wjsc.v8.i3.73","article-title":"Homing and migration of mesenchymal stromal cells: how to improve the efficacy of cell therapy?","volume":"8","author":"De Becker","year":"2016","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.vph.2025.107491_bb0545","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.isci.2019.05.004","article-title":"Mesenchymal stromal cell homing: mechanisms and strategies for improvement","volume":"15","author":"Ullah","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.vph.2025.107491_bb0550","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1182\/blood-2002-06-1830","article-title":"Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates","volume":"101","author":"Devine","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.vph.2025.107491_bb0555","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","article-title":"Mesenchymal stem cell homing: the devil is in the details","volume":"4","author":"Karp","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.vph.2025.107491_bb0560","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12872-015-0162-6","article-title":"Atorvastatin treatment improves effects of implanted mesenchymal stem cells: meta-analysis of animal models with acute myocardial infarction","volume":"15","author":"Dai","year":"2015","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.vph.2025.107491_bb0565","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/cvr\/cvz139","article-title":"Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19","volume":"116","author":"Huang","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0500","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9824698","article-title":"In vivo immunogenic response to allogeneic mesenchymal stem cells and the role of preactivated mesenchymal stem cells Cotransplanted with allogeneic islets","volume":"2017","author":"Oliveira","year":"2017","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.vph.2025.107491_bb0620","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.mt.6300374","article-title":"Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance","volume":"16","author":"Cheng","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.vph.2025.107491_bb0625","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jtcvs.2007.07.071","article-title":"Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis","volume":"135","author":"Hu","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.vph.2025.107491_bb0630","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/stem.580","article-title":"A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling","volume":"29","author":"Xiong","year":"2011","journal-title":"Stem Cells Dayt. Ohio"},{"key":"10.1016\/j.vph.2025.107491_bb0635","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jtcvs.2007.07.028","article-title":"Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function","volume":"134","author":"Suuronen","year":"2007","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.vph.2025.107491_bb0640","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCRESAHA.109.212589","article-title":"Magnetic targeting enhances engraftment and functional benefit of Iron-labeled cardiosphere-derived cells in myocardial infarction","volume":"106","author":"Cheng","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0645","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000367","article-title":"Cellular encapsulation enhances cardiac repair","volume":"2","author":"Levit","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.vph.2025.107491_bb0650","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/nm912","article-title":"Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts","volume":"9","author":"Mangi","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2025.107491_bb0655","doi-asserted-by":"crossref","first-page":"H2196","DOI":"10.1152\/ajpheart.01017.2005","article-title":"Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance","volume":"290","author":"Berry","year":"2006","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2025.107491_bb0660","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1161\/CIRCRESAHA.109.196030","article-title":"Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium","volume":"106","author":"Huang","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0665","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000347081","article-title":"Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction","volume":"125","author":"Huang","year":"2013","journal-title":"Cardiology"},{"key":"10.1016\/j.vph.2025.107491_bb0670","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/art.27736","article-title":"Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells","volume":"62","author":"Bocelli-Tyndall","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.vph.2025.107491_bb0675","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1073\/pnas.142298299","article-title":"Characterization of the expression of MHC proteins in human embryonic stem cells","volume":"99","author":"Drukker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.vph.2025.107491_bb0680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010192","article-title":"Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells","volume":"5","author":"Su\u00e1rez-Alvarez","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vph.2025.107491_bb0685","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcyt.2018.02.003","article-title":"Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells","volume":"20","author":"Guan","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.vph.2025.107491_bb0690","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12014-017-9161-1","article-title":"Interferon \u03b3 induced compositional changes in human bone marrow derived mesenchymal stem\/stromal cells","volume":"14","author":"Guan","year":"2017","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.vph.2025.107491_bb0695","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.humimm.2013.06.025","article-title":"Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry","volume":"74","author":"Gragert","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.vph.2025.107491_bb0700","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4586398","article-title":"The effects of programmed cell death of mesenchymal stem cells on the development of liver fibrosis","volume":"2023","author":"Wu","year":"2023","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.vph.2025.107491_bb0705","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.3324\/haematol.2018.214767","article-title":"Apoptotic mesenchymal stromal cells induce prostaglandin E2 in monocytes: implications for the monitoring of mesenchymal stromal cell activity","volume":"104","author":"Cheung","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.vph.2025.107491_bb0710","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.tibtech.2018.11.012","article-title":"Extracellular microvesicles as new industrial therapeutic","volume":"37","author":"Agrahari","year":"2019","journal-title":"Frontiers Trends Biotechnol."},{"key":"10.1016\/j.vph.2025.107491_bb0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0362-8","article-title":"Apoptotic cell-derived exosomes: messages from dying cells","volume":"52","author":"Kakarla","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.vph.2025.107491_bb0720","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s12015-020-10071-0","article-title":"Ex vivo induction of apoptotic mesenchymal stem cell by high hydrostatic pressure","volume":"17","author":"Le","year":"2021","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.vph.2025.107491_bb0725","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.vph.2025.107491_bb0730","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41423-023-01018-9","article-title":"The critical role of apoptosis in mesenchymal stromal cell therapeutics and implications in homeostasis and normal tissue repair","volume":"20","author":"Giacomini","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.vph.2025.107491_bb0735","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.ymthe.2023.10.004","article-title":"Apoptosis in mesenchymal stromal cells activates an immunosuppressive secretome predicting clinical response in Crohn\u2019s disease","volume":"31","author":"Cheung","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.vph.2025.107491_bb0740","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01191","article-title":"Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs","volume":"10","author":"Weiss","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vph.2025.107491_bb0745","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1038\/s41467-021-26834-3","article-title":"Mesenchymal stromal cell apoptosis is required for their therapeutic function","volume":"12","author":"Pang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.vph.2025.107491_bb0750","doi-asserted-by":"crossref","DOI":"10.1093\/stcltm\/szae061","article-title":"Cryopreserved apoptotic mesenchymal stromal cells retain functional efficacy in suppressing an allergic inflammation in a murine model","author":"Amison","year":"2024","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.vph.2025.107491_bb0755","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/cells8121605","article-title":"Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases","volume":"8","author":"Harrell","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.vph.2025.107491_bb0760","first-page":"1","article-title":"Mesenchymal stem cells attenuate liver fibrosis by targeting Ly6Chi\/lo macrophages through activating the cytokine-paracrine and apoptotic pathways","volume":"7","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.vph.2025.107491_bb0765","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1016\/j.celrep.2020.02.062","article-title":"Mesenchymal stem and stromal cells harness macrophage-derived Amphiregulin to maintain tissue homeostasis","volume":"30","author":"Ko","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.vph.2025.107491_bb0770","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mvr.2008.02.005","article-title":"Therapeutic potential of angiogenin modified mesenchymal stem cells: angiogenin improves mesenchymal stem cells survival under hypoxia and enhances vasculogenesis in myocardial infarction","volume":"76","author":"Liu","year":"2008","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0775","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1089\/biores.2019.0012","article-title":"Enhancement of cellular adhesion and proliferation in human mesenchymal stromal cells by the direct addition of recombinant collagen I peptide to the culture medium","volume":"8","author":"Muraya","year":"2019","journal-title":"BioResearch Open Access"},{"key":"10.1016\/j.vph.2025.107491_bb0780","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.yexcr.2016.03.024","article-title":"Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction","volume":"344","author":"Zhao","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.vph.2025.107491_bb0785","first-page":"2734","article-title":"Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction, stem cells dayt","volume":"27","author":"Mias","year":"2009","journal-title":"Ohio"},{"key":"10.1016\/j.vph.2025.107491_bb0790","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.yjmcc.2010.09.001","article-title":"Mesenchymal stem cells stimulate protective genetic reprogramming of injured cardiac ventricular myocytes","volume":"50","author":"Rogers","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.vph.2025.107491_bb0795","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nm0405-367","article-title":"Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells","volume":"11","author":"Gnecchi","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2025.107491_bb0800","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ymthe.2006.05.016","article-title":"Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation","volume":"14","author":"Noiseux","year":"2006","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.vph.2025.107491_bb0805","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cardiores.2005.02.006","article-title":"Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia","volume":"66","author":"Iwase","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0810","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13287-018-0791-7","article-title":"Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine","volume":"9","author":"Keshtkar","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.vph.2025.107491_bb0815","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","article-title":"The secretion profile of mesenchymal stem cells and potential applications in treating human diseases","volume":"7","author":"Han","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.vph.2025.107491_bb0820","doi-asserted-by":"crossref","first-page":"1609206","DOI":"10.1080\/20013078.2019.1609206","article-title":"Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications","volume":"8","author":"Witwer","year":"2019","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.vph.2025.107491_bb0825","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/CCM.0000000000002328","article-title":"Exosomes in critical illness","volume":"45","author":"Terrasini","year":"2017","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.vph.2025.107491_bb0830","doi-asserted-by":"crossref","first-page":"13058","DOI":"10.3390\/cimb46110779","article-title":"Differences in plasma extracellular vesicles of different origin in on-pump versus off-pump cardiac surgery","volume":"46","author":"Aquino","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.vph.2025.107491_bb0835","article-title":"Graft-derived extracellular vesicles transport miRNAs to modulate macrophage polarization after heart transplantation","author":"Zheng","year":"2024","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.vph.2025.107491_bb0840","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-022-05034-x","article-title":"Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?","volume":"13","author":"Kou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.vph.2025.107491_bb0845","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/stem.2575","article-title":"Concise review: MSC-derived exosomes for cell-free therapy","volume":"35","author":"Phinney","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.vph.2025.107491_bb0850","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1089\/scd.2013.0479","article-title":"Mesenchymal stem cells secrete immunologically active exosomes","volume":"23","author":"Zhang","year":"2014","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.vph.2025.107491_bb0855","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3350\/cmh.2020.0194","article-title":"The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future","volume":"27","author":"Watanabe","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.vph.2025.107491_bb0860","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12929-021-00725-7","article-title":"Mesenchymal stem\/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications","volume":"28","author":"Zhuang","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.vph.2025.107491_bb0865","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.vph.2025.107491_bb0870","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02538","article-title":"Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function","volume":"9","author":"Reis","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vph.2025.107491_bb0875","doi-asserted-by":"crossref","unstructured":"T. Lener, M. Gimona, L. Aigner, V. B\u00f6rger, E. Buzas, G. Camussi, N. Chaput, D. Chatterjee, F.A. Court, H.A. del Portillo, L. O'Driscoll, S. Fais, J.M. Falcon-Perez, U. Felderhoff-Mueser, L. Fraile, Y.S. Gho, A. G\u00f6rgens, R.C. Gupta, A. Hendrix, D.M. Hermann, A.F. Hill, F. Hochberg, P.A. Horn, D. de Kleijn, L. Kordelas, B.W. Kramer, E.-M. Kr\u00e4mer-Albers, S. Laner-Plamberger, S. Laitinen, T. Leonardi, M.J. Lorenowicz, S.K. Lim, J. L\u00f6tvall, C.A. Maguire, A. Marcilla, I. Nazarenko, T. Ochiya, T. Patel, S. Pedersen, G. Pocsfalvi, S. Pluchino, P. Quesenberry, I.G. Reischl, F.J. Rivera, R. Sanzenbacher, K. Schallmoser, I. Slaper-Cortenbach, D. Strunk, T. Tonn, P. Vader, B.W.M. van Balkom, M. Wauben, S.E. Andaloussi, C. Th\u00e9ry, E. Rohde, B. Giebel, Applying extracellular vesicles based therapeutics in clinical trials \u2013 an ISEV position paper, J. Extracell. Vesicles 4 (2015) https:\/\/doi.org\/10.3402\/jev.v4.30087. doi: 10.3402\/jev.v4.30087.","DOI":"10.3402\/jev.v4.30087"},{"key":"10.1016\/j.vph.2025.107491_bb0880","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/ijms18071450","article-title":"Mesenchymal stem\/stromal cell-derived extracellular vesicles and their potential as novel immunomodulatory therapeutic agents","volume":"18","author":"B\u00f6rger","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vph.2025.107491_bb0885","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/sctm.17-0055","article-title":"Concise review: developing best-practice models for the therapeutic use of extracellular vesicles","volume":"6","author":"Reiner","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.vph.2025.107491_bb0890","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s41232-024-00340-7","article-title":"Extracellular vesicles from dental pulp mesenchymal stem cells modulate macrophage phenotype during acute and chronic cardiac inflammation in athymic nude rats with myocardial infarction","volume":"44","author":"Amaro-Prellezo","year":"2024","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.vph.2025.107491_bb0895","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cvr\/cvu167","article-title":"Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction","volume":"103","author":"Barile","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0900","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/cvr\/cvy055","article-title":"Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-a","volume":"114","author":"Barile","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2025.107491_bb0905","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3389\/fphys.2012.00359","article-title":"Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy","volume":"3","author":"Baglio","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.vph.2025.107491_bb0910","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1038\/s41598-019-42063-7","article-title":"Extracellular vesicles from apoptotic cells promote TGF\u03b2 production in macrophages and suppress experimental colitis","volume":"9","author":"Chen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vph.2025.107491_bb0915","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/imt-2017-0117","article-title":"Immune modulation by apoptotic dental pulp stem cells in vivo","volume":"10","author":"Laing","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.vph.2025.107491_bb0920","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s13287-020-02014-w","article-title":"Apoptotic bodies derived from mesenchymal stem cells promote cutaneous wound healing via regulating the functions of macrophages","volume":"11","author":"Liu","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.vph.2025.107491_bb0925","doi-asserted-by":"crossref","unstructured":"H. Liu, S. Liu, X. Qiu, X. Yang, L. Bao, F. Pu, X. Liu, C. Li, K. Xuan, J. Zhou, Z. Deng, S. Liu, Y. Jin, Donor MSCs release apoptotic bodies to improve myocardial infarction via autophagy regulation in recipient cells, Autophagy 16 (n.d.) 2140\u20132155. doi: https:\/\/doi.org\/10.1080\/15548627.2020.1717128.","DOI":"10.1080\/15548627.2020.1717128"},{"key":"10.1016\/j.vph.2025.107491_bb0930","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrm2312","article-title":"Apoptosis: controlled demolition at the cellular level","volume":"9","author":"Taylor","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.vph.2025.107491_bb0935","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jpi.12140","article-title":"Additional benefit of combined therapy with melatonin and apoptotic adipose-derived mesenchymal stem cell against sepsis-induced kidney injury","volume":"57","author":"Chen","year":"2014","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.vph.2025.107491_bb0940","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41422-018-0070-2","article-title":"Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors","volume":"28","author":"Liu","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.vph.2025.107491_bb0945","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba2987","article-title":"Chimeric apoptotic bodies functionalized with natural membrane and modular delivery system for inflammation modulation","volume":"6","author":"Dou","year":"2020","journal-title":"Sci. Adv."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189125000308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189125000308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T23:05:53Z","timestamp":1748905553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189125000308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":188,"alternative-id":["S1537189125000308"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2025.107491","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical translation of mesenchymal stem cells in ischemic heart failure: Challenges and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2025.107491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107491"}}